piracetam has been researched along with Asthma, Bronchial in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty outpatients given systemic corticosteroid therapy for asthma were randomized to either levetiracetam (1500 mg/day) or placebo given concurrently with the corticosteroids." | 5.12 | Impact of levetiracetam on mood and cognition during prednisone therapy. ( Bret, ME; Brown, ES; Frol, AB; Khan, DA; Larkin, GL, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, ES | 1 |
| Frol, AB | 1 |
| Khan, DA | 1 |
| Larkin, GL | 1 |
| Bret, ME | 1 |
1 trial available for piracetam and Asthma, Bronchial
| Article | Year |
|---|---|
Impact of levetiracetam on mood and cognition during prednisone therapy.
Topics: Adolescent; Adult; Affect; Aged; Anti-Inflammatory Agents; Antidepressive Agents; Asthma; Cognition; | 2007 |